Downloads: 137 | Views: 266

Research Paper | Medicine Science | India | Volume 6 Issue 1, January 2017 | Popularity: 6.1 / 10

Rate This Article!      

Financial Implications in Management of Multidrug Resistant Tuberculosis in India

Dr. Jairaj P Nair, Dr. Amita U Athavale, Dr. Vijay S Khatri, Dr. Tanjul Saxena

Abstract: Aim To calculate total cost incurred by patients for Multi-drug Resistant Tuberculosis (MDR-TB) management and evaluate their financial resources. Financial details regarding MDR-TB management were collected from 30 patients. Average daily drugs cost was Rs.166.83. Average family monthly income was Rs.8333.33. Average Per Capita Income was Rs.1473.67. Financial help for treatment was provided by self-funding, relatives, socio-religious groups, hospital supply & stockists. Total cost of MDR-TB management is Rs.140752.50. Including sensitive first line MDR-TB drugs reduces cost remarkably.90 % of the study group belonged to economically productive age group. Institutional treatment is the cheapest mode.

Keywords: Economical, Resources, funding, Cost, Expensive

Edition: Volume 6 Issue 1, January 2017

Pages: 535 - 539

DOI: https://www.doi.org/10.21275/ART20164116

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article